Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Could hep C medications be used to prevent infection in the first place?
A potent new opiate called carfentanil has hit the U.S. drug supply and is driving up overdoses across the country.
For some, out-of-pocket costs may run as high as tens of thousands of dollars.
The Cincinnati Enquirer investigates what the Southern city has done to help quell opioid addiction better than almost anywhere else.
This holds true particularly for those who are younger and healthier and those in communities with lower hep C prevalence among users.
Tatjana Reic, President of the European Liver Patients Association (ELPA), tells her viral hepatitis story.
Research shows that hepatitis C can survive on a surface for up to six weeks.
Injury rates caused by a variety of teas, herbs, vitamins, minerals and diet pills have more than doubled over the last 10 years.
After the unsuccessful outcome of her first hepatitis C treatment, determination and optimism paid off
The move to begin testing for this common co-infection is part of the organization’s goal to end AIDS as an epidemic in New York by 2020.
Compounding the problem, state prison systems do not have access to the drug discounts that certain federal agencies do.
Last month, 35 states and the District of Columbia sued the makers of this popular medication-assisted treatment in a federal court probe.
The black-box warning, which applies to all hep C medications, is the most serious the health agency can give.
Tragedies can be avoided, but only if we pursue the path of truth